Differences in Immunohistochemical Expression of Xenobiotic-Metabolizing Enzymes Between Normal Pancreas,Chronic Pancreatitis and Pancreatic Cancer

Abstract

Metabolic activation of many toxins, carcinogens, drugs, and anti-cancer agents is governed by the cytochrome P450 (CYP) drug-metabolizing enzyme system. To help elucidate the role of this enzyme system in the pathogenesis of chronic inflammatory and malignant pancreatic diseases, we compared the immunohistochemical expression pattern of 8 CYP-enzymes in 24 normal, 20 chronic pancreatitis, and 21 pancreatic cancer specimens using antibodies to CYP 1A1, 1A2, 2B6, 2C8/9/19, 2D6, 2E1, and 3A4, and the NADPH cytochrome P450 oxido-reductase (NA-OR). Compared to the normal pancreas, a higher frequency of immunopositivity for CYP 1A2, 2B6, 2C8/9/19, 2D6, and NA-OR was found in chronic pancreatitis, and of all CYPs but 1A2 in pancreatic cancer. On the other hand, CYP 1A1 and 2E1 antibody staining was less frequently observed in chronic pancreatitis. In all specimens with pancreatic polypeptide (PP)-rich regions (pancreas head), more islet cells than ductal and acinar cells were immunopositive. Moreover, the immunoreactivity of islet cells from PP-rich specimens with anti-CYP antibodies was consistently more frequent and intense than in islet cells from PP-poor areas (body and tail). Immunoreactivity for xenobiotic-metabolizing enzymes was frequently observed in the normal pancreas, chronic pancreatitis, and pancreatic cancer, and displayed differences of its frequency and intensity between the 3 groups. Considering immunohistochemical evidence of enzyme expression and pancreatic blood supply together, islet cells appear to be an important and possible early site of CYP-enzyme induction in pancreatic diseases.

Keywords

Cytochrome P450 drug metabolism islets of Langerhans pancreatic polypeptide.

References

Bestervelt LL , Vaz AD , Coon MJ -1995-. Inactivation of ethanol-inducible cytochrome P450 and other microsomal P450 isozymes by trans-4-hydroxy2-nonenal, a major product of membrane lipid peroxidation. Proc Natl Acad Sci USA 92: 3764—3768.

Boyer TD -1989-. The glutathione S-transferases: An update. Hepatology 9: 486—496.

Braganza JM -1998-. A framework for the aetiogenesis of chronic pancreatitis . Digestion 59: 1—12.

Foster JR , Idle JR , Hardwick JP , Bars R. , Scott P. , Braganza JM -1993-. Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis. J Pathol 169: 457—463.

Gibson GG , Skett P. -1994-. Introduction to Drug Metabolism. Chapman and Hall, London.

Guengerich FP -1988-. Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res 48: 2946—2954.

Hirvonen A. -1999-. Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. Environ Health Perspect 107-Suppl 1-: 37—47.

Jounaidi Y. , Waxman DJ -2001-. Frequent, moderate-dose cyclophosphamide administration improves the efficacy of cytochrome P-450/ cytochrome P-450 reductase-based cancer gene therapy. Cancer Res 61: 4437— 4444.

Kaminsky LS , Spivack SD -1999-. Cytochromes P450 and cancer. Mol Aspects Med 20: 70—84.

10.

Kan O. , Griffiths L. , Baban D. , Iqball S. , Uden M. , Spearman H. , Slingsby J. , Price T. , Esapa M. , Kingsman S. , Kingsman A. , Slade A. , Naylor S. -2001-. Direct retroviral delivery of human cytochrome P450 2B6 for gene-directed enzyme prodrug therapy of cancer. Cancer Gene Ther 8: 473—482.

11.

Koop DR -1997-. Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J 6: 724—730.

12.

Kunitoh S. , Imaoka S. , Hiroi T. , Yabusaki Y. , Monna T. , Funae Y. -1997-. Acetaldehyde as well as ethanol is metabolized by human CYP2E1. J Pharmacol Exp Ther 280: 527—532.

13.

Lewis DF , Ioannides C. , Parke DV -1998-. Cytochromes P450 and species differences in xenobiotic metabolism and activation of carcinogen. Environ Health Perspect 106: 633—641.

14.

Nakajima T. , Wang RS , Nimura Y. , Pin YM , He M. , Vainio H. , Murayama N. , Aoyama T. , Iida F. -1996-. Expression of cytochrome P450s and glutathione S-transferases in human esophagus with squamous-cell carcinomas. Carcinogenesis 17: 1477—1481.

15.

Norton ID , Apte MV , Haber PS , McCaughan GW , Pirola RC , Wilson JS -1998-. Cytochrome P4502E1 is present in rat pancreas and is induced by chronic ethanol administration. Gut 42: 426—430.

16.

Pelkonen O. -1992-. Carcinogen metabolism and individual susceptibility. Scand J Work Environ Health 18: 17—21.

17.

Pour PM , Kazakoff K. , Dulany K. -1994-. A new technique for simultaneous demonstration of 4 tumor-associated antigens in pancreatic cancer cells. Zentralbl Pathol 140: 397—401.

18.

Pour PM , Schmied BM , Ulrich AB , Friess H. , Andren-Sandberg A. , Buchler MW -2000-. Abnormal differentiation of islet cells in pancreatic cancer. Pancreatology 1: 110—116.

19.

Rendic S. , Di Carlo FJ -1997-. Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev 29: 413—580.

20.

Schmied BM , Ulrich AB , Matsuzaki H. , Li C. , Friess H. , Buechler MW , Andren-Sandberg A. , Adrian TE , Pour PM - 2000-. Alteration of the langerhans islet in pancreatic cancer patients. Int J Pathol 28: 187—197.

21.

Standop J. , Schneider MB , Ulrich A. , Chauhan S. , Moniaux N. , Buchler MW , Batra SK , PourPM - 2002-. The pattern of xenobiotic-metabolizing enzymes in the human pancreas. J Toxicol Environ Health A 65: 1379—1400.

22.

Standop J. , Ulrich A. , Schneider M. , Buchler MW , Pour PM - 2002-. Differences in the expression of xenobiotic-metabolizing enzymes between islets derived from the ventral and dorsal Anlage of the pancreas . Pancreatology 2: 510—518.

23.

Ulrich A. , Schmied BM , Standop J. , Schneider MB , Lawson T. , Friess H. , Andren-Sandberg A. , Buchler MW , Pour PM - 2002-. Differences in the expression of glutathione S-transferases in normal pancreas, chronic pancreatitis, secondary chronic pancreatitis and pancreatic cancer. Pancreas 24: 291—297.

24.

Ulrich AB , Schmied BM , Matsuzaki H. , Lawson TA , Friess H. , Andren-Sandberg A. , Buchler MW , Pour PM - 2001-. Increased expression of glutathione S-transferase-pi in the islets of patients with primary chronic pancreatitis but not secondary chronic pancreatitis. Pancreas 22: 388—394.

25.

Ulrich AB , Standop J. , Schmied BM , Schneider MB , Lawson TA , Pour PM - 2002-. Species Differences in the Distribution of Drug-metabolizing Enzymes in the Pancreas. Toxicol Pathol 30: 247—253.

26.

Wacke R. , Kirchner A. , Prall F. , Nizze H. , Schmidt W. , Fischer U. , Nitschke FP , Adam U. , Fritz P. , Belloc C. , Drewelow B. -1998-. Up-regulation of cytochrome P450 1A2, 2C9, and 2E1 in chronic pancreatitis. Pancreas 16: 521—528.

27.

Wallig MA -1998-. Xenobiotic metabolism, oxidant stress and chronic pancreatitis. Focus on glutathione. Digestion 59: 13—24.

28.

Yokose T. , Doy M. , Taniguchi T. , Shimada T. , Kakiki M. , Horie T. , Matsuzaki Y. , Mukai K. -1999-. Immunohistochemical study of cytochrome P450 2C and 3A in human non-neoplastic and neoplastic tissues. Virchows Arch 434: 401—411.

29.

Yu MW , Gladek-Yarborough A. , Chiamprasert S. , Santella RM , Liaw YF , Chen CJ - 1995-. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology 109: 1266—1273.

30.

Zhang L. , Weddle DL , Thomas PE , Zheng B. , Castonguay A. , Schuller HM , Miller MS -2000-. Low levels of expression of cytochromes P-450 in normal and cancerous fetal pancreatic tissues of hamsters treated with NNK and/or ethanol. Toxicol Sci 56: 313—323.